FREE Account Opening + No Clearing Fees
Loading...
April 30, 2018 - May 3, 2018

Indo US BioTech IPO Latest News Today

Track all the latest updates and news of Indo US BioTech IPO.

  1. Why This Hot Biotech IPO Might Just Be a Winning Bet

    March 15, 2024 9:26:28 AM

    The biotech industry is currently experiencing a period of cautious optimism, presenting potential opportunities ...

    Published by : The UBJ on MSN
  2. Why That Hot Biotech IPO Could Be a Winner

    March 14, 2024 2:30:00 PM

    Biotechnology IPOs tend to do well over the long term just as financing markets begin to thaw, an analysis shows.

    Published by : Wall Street Journal on MSN
  3. Indo US Bio-Tech Ltd Share Price

    March 27, 2024 3:30:00 AM

    Indo US Bio-Tech Ltd share price was down by -5.19% from the previous closing price of ?212.00. Who are peers of Indo US Bio-Tech Ltd? The peers of Indo US Bio-Tech Ltd are BSE Ltd, NBCC (India ...

    Published by : Business Today
  4. Boundless Bio bumps IPO market back to life after sleepy few weeks

    March 6, 2024 7:50:00 PM

    Just when it seemed like the biotech IPOs were being lulled back to sleep, Boundless Bio says it plans to hit Wall Street. The Arch-, Bayer- and RA-backed company filed an S-1 Wednesday afternoon ...

    Published by : FierceBiotech
  5. IPOs: is the party really over?

    April 5, 2019 11:13:00 AM

    As Nature Biotechnology went to press, one US biotech IPO had been completed, one withdrawn, and one remained pending in 1999. Put in simple terms, around 80% of the US biotechnology sector has a ...

    Published by : Nature
  6. Acelyrin raises $540 million in rare biotech IPO

    May 5, 2023 3:30:00 AM

    The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...

    Published by : pharmaphorum
  7. Boundless Bio eyes $88M offering as spring biotech IPO market blooms

    March 21, 2024 12:20:00 PM

    Boundless Bio�s announcement earlier this month of plans to go public was a sign that the biotech IPO window hadn�t slammed ... Boundless expects "net proceeds to us from this offering will ...

    Published by : FierceBiotech
  8. Biotech IPOs heated up to start 2024. Will the surge last?

    March 5, 2024 2:30:00 AM

    After more than two years in the doldrums, initial public offerings, an important indicator of the biotechnology ... behind us.� Yet it�s unclear whether that�s the case for IPOs.

    Published by : Yahoo Finance
  9. EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings

    March 21, 2024 6:34:00 PM

    Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...

    Published by : Benzinga.com
  10. Indo Us Bio-Tech share price

    March 15, 2024 3:30:00 AM

    10/-. 07-Mar-19 24-Apr-19 23-Apr-19 Bonus issue in the ratio of 1:4 of Rs. 10/-. Indo US Bio-Tech Limited is engaged in research and development throw breeding, production of seeds, processing ...

    Published by : Mint
  11. Why That Hot Biotech IPO Could Be a Winner

    March 14, 2024 3:30:00 PM

    The best time to make money in biotech is usually during periods of cautious optimism. There are strong signs that right now might be one of those moments. The always-volatile industry has just ...

    Published by : Wall Street Journal
  12. Why That Hot Biotech IPO Could Be a Winner

    March 15, 2024 6:19:00 AM

    Biotechnology IPOs tend to do well over the long term just as financing markets begin to thaw, an analysis shows. The best time to make money in biotech is usually during periods of cautious optimism.

    Published by : Mint

Indo US BioTech IPO Alerts

1. Indo US BioTech IPO Listing Date & Info  Tuesday, May 15, 2018 6:16:22 AM

The IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:

  • Listing Date: Friday, May 11, 2018
  • BSE Script Code: 541304
  • NSE Symbol:
  • Listing In: MT
  • ISIN: INE250Z01010
  • Issue Price: 51
  • Face Value: 10

2. Indo US BioTech IPO Allotment Status  Tuesday, May 8, 2018 11:38:36 AM

The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.

3. Indo US BioTech IPO Closes on May 3, 2018  Tuesday, April 17, 2018 8:41:07 AM

The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

4. Indo US BioTech IPO Opens on Apr 30, 2018  Sunday, April 8, 2018 3:10:43 AM

Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.

The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.

Indo US BioTech IPO News & Events FAQs

The Indo US BioTech IPO is proposed to open on April 30, 2018. The IPO application ends on May 3, 2018.

Retail investors can apply in the retail or non-institutional investor category from April 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Indo US BioTech IPO will open for subscription on April 30, 2018. The public issue will close on May 3, 2018.